Hct Hexal (Hydrochlorothiazide)

Hct Hexal is prescribed for conditions where reduction of excess fluid or lowering of blood pressure is needed.

• Hypertension (high blood pressure)
• Edema associated with congestive heart failure
• Edema due to hepatic cirrhosis
• Edema related to chronic kidney disease
• Prevention of calcium‑containing kidney stones

The safety profile of Hct Hexal reflects the typical effects observed with thiazide diuretics, ranging from mild, frequently reported symptoms to rare but serious reactions.

Common

• Increased frequency of urination
• Dizziness or light‑headedness, especially after standing
• Headache
• Low potassium levels (hypokalemia)

Serious

• Severe dehydration or electrolyte imbalance
• Allergic reactions such as rash, itching, or angioedema
• Blood disorders including agranulocytosis or leukopenia

When prescribing Hct Hexal, clinicians consider several precautionary factors to minimize risks and ensure appropriate use.

• Assess renal and hepatic function before initiating therapy
• Monitor serum electrolytes, especially potassium and sodium
• Use cautiously in patients with a history of gout
• Adjust dose in diabetic patients due to potential effects on glucose control
• Pregnancy category is unknown; avoid use unless clearly needed
• Elderly patients may be more sensitive to volume depletion

Hydrochlorothiazide can affect the pharmacokinetics or pharmacodynamics of other medicines, so awareness of potential interactions is important.

Avoid

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) which may blunt diuretic effect
• Lithium, because thiazides can increase lithium levels and toxicity
• Digoxin, as electrolyte changes may predispose to toxicity
• ACE inhibitors or ARBs without monitoring potassium levels

Use with caution

• Antidiabetic agents (risk of hypoglycemia)
• Corticosteroids (enhanced fluid loss)
• Antihistamines that cause drowsiness
• Other diuretics, which may cause excessive dehydration